GlycoMantra is one of the featured companies that the Maryland Department of Commerce is showcasing…
GlycoMantra has been awarded a two-year SBIR grant from the NIAID (NIH) to investigate COVID-19-impacted type 2 diabetes.
Related Posts
GlycoMantra received a SBIR Phase 1 grant from the NIDDK (NIH) June 03, 2020 GlycoMantra…
GlycoMantra will present at the Oncology Investor Conference. GlycoMantra has been selected to pitch at the…